(Q63573757)
Statements
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) (English)
0 references
26 March 2019
0 references
November 2020
0 references
1,088
0 references
45 year
0 references